In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:
Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Industrial Costs of Developing and Commercializing Childhood Vaccines, RFA IP 06-010.
Time and Date: 12 p.m.-4 p.m., June 29, 2006 (Closed).
Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to “Industrial Costs of Developing and Commercializing Childhood Vaccines,” RFA IP 06-010.
For Further Information Contact: Christine Morrison, Ph.D., Scientific Review Administrator, Office of Extramural Research, CDC, 1600 Clifton Road NE, Mailstop D72, Atlanta, GA 30333, Telephone (404) 639-3098.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.Start Signature
Dated: May 11, 2006.
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. E6-7635 Filed 5-18-06; 8:45 am]
BILLING CODE 4163-18-P